Daniel Moore MD PhD

Pediatric Diabetes Endocrinology

Associate Professor, Pediatrics and Pathology, Microbiology&Immunology, Vanderbilt University School of Medicine

2601 21st Ave SNashville, TN 37232
Phone+1 615-322-4916
Fax+1 615-936-0605

Dr. Moore is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moore's full profile Already have an account?

Summary

Dr. Daniel Moore is a pediatric endocrinologist based in Nashville, TN, specializing in pediatric diabetes endocrinology. He completed his fellowship in Pediatric Endocrinology at Vanderbilt University Medical Center, where he is currently an Associate Professor and the Director of the Pediatric Physician Scientist Training Program. He also serves as an Associate Professor at Vanderbilt University School of Medicine. His research interests include autoimmune disease and immune therapy, with numerous publications in the field of type 1 diabetes. Dr. Moore has been involved in clinical trials related to type 1 diabetes and has received multiple honors, including the Scholar in Diabetes Award and Alpha Omega Alpha membership.

Education & Training

Vanderbilt University Medical CenterFellowship, Pediatric Endocrinology, 2007 - 2010
Vanderbilt University Medical CenterResidency, Pediatrics, 2004 - 2007
Perelman School of Medicine at the University of PennsylvaniaClass of 2004

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TN State Medical License 2007 - 2028
AL State Medical License 2020 - 2020
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

Alpha Omega Alpha 2018
Top Doctor Castle Connolly, 2016
Focus on the Cure Award Juvenile Diabetes Research Foundation, 2012

Clinical Trials

ATG-GCSF in New Onset Type 1 Diabetes
COMPLETED
PHASE2
Tocilizumab (TCZ) in New-onset Type 1 Diabetes Start of enrollment: 2015 Mar 12
COMPLETED
PHASE2
Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)
COMPLETED
PHASE2

Publications & Presentations

PubMed

Dual Modulation of Prostaglandin E2 Receptors EP3 and EP4 Protects β-Cell Mass in a Model of Aggressive Autoimmune Inflammation.
Juliann B Burkett, Jennifer Fuhr, Alexander C Falk, Prasanna Dadi, Alexa N Del Bene
Diabetes. 2026-07-31
Response to From Systemic B-Cell Targeting to Local Immune Engineering in Islet Transplantation.
Christopher S Wilson, Daniel J Moore
Diabetes. 2026-04-01
2 citations
B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes.
Christopher S Wilson, Blair T Stocks, Alexander C Falk, Daniel J Moore
Diabetes. 2026-01-20

Journal Articles

Cutting Edge: IL-1α and Not IL-1β Drives IL-1R1–Dependent Neonatal Murine Sepsis Lethality
James L Wynn, John T Benjamin, Daniel J Moore, The Journal of Immunology

Press Mentions

Academy for Excellence in Education Elects 28 New MembersJune 16th, 2021

Grant Support

How B lymphocytes prevent transplantation tolerance in T1DBeatson Foundation2019–2021
Career Development Award: Mapping a Cure By Defining the B Lymphocyte Signaling NetworkJuvenile Diabetes Research Foundation2014–2019
The Contribution of B Lymphocytes to T1D Reversal by ImatinibNIH2016–2018
High Throughput Identification of Treg Activating MoleculesNIH2015–2017
RESTORATION OF IMMUNE TOLERANCE IN TYPE 1 DIABETESNIDDK2012–2014